We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+10.3%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$3.7B
AUM Growth
+$254M
Cap. Flow
-$65M
Cap. Flow %
-1.76%
Top 10 Hldgs %
30.99%
Holding
194
New
8
Increased
30
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.2M
2
SONY icon
Sony
SONY
+$1.09M
3
FRO icon
Frontline
FRO
+$741K
4
ORCL icon
Oracle
ORCL
+$550K
5
PHG icon
Philips
PHG
+$435K

Sector Composition

Rank Sector Weight
1 Technology 34.09%
2 Industrials 19.8%
3 Healthcare 19.73%
4 Consumer Staples 12.67%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
176
NextEra Energy
NEE
$185B
$242K 0.01%
4,000
JNPR
177
DELISTED
Juniper Networks
JNPR
$239K 0.01%
9,700
-4,808
-33% -$118K
D icon
178
Dominion Energy
D
$62B
$232K 0.01%
2,800
ITUB icon
179
Itaú Unibanco
ITUB
$91.7B
$229K 0.01%
34,358
-278
-0.8% -$1.74K
BHP icon
180
BHP
BHP
$211B
$226K 0.01%
4,633
ETSY icon
181
Etsy
ETSY
$7.85B
$222K 0.01%
5,000
PNC icon
182
PNC Financial Services
PNC
$100B
$212K 0.01%
+1,327
New +$199K
PCTI
183
DELISTED
PCTEL, Inc. Common Stock
PCTI
$212K 0.01%
25,000
CRSP icon
184
CRISPR Therapeutics
CRSP
$4.67B
$207K 0.01%
+3,400
New +$186K
EDIT icon
185
Editas Medicine
EDIT
$407M
$204K 0.01%
+6,900
New +$172K
ORAN
186
DELISTED
Orange
ORAN
$183K 0.01%
12,526
UBX
187
DELISTED
Unity Biotechnology
UBX
$151K ﹤0.01%
2,100
SAN icon
188
Banco Santander
SAN
$199B
$42K ﹤0.01%
10,519
CULP icon
189
Culp Inc
CULP
$46.7M
-16,000
Closed -$261K
WDC icon
190
Western Digital
WDC
$168B
-8,600
Closed -$388K
ZUMZ icon
191
Zumiez
ZUMZ
$327M
-10,000
Closed -$317K
CBLK
192
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-12,500
Closed -$325K
CELG
193
DELISTED
Celgene Corp
CELG
-205,789
Closed -$20.4M

Similar funds

Saturna Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Saturna Capital held 194 positions worth $3.7B, up 7.4% from $3.44B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Saturna Capital's Q4 2019 filing shows 8 new, 30 increased, 27 reduced and 6 closed positions. Its largest new stake was Sony: 87,500 shares worth $1.19M. The largest sale was Johnson & Johnson, an estimated $23.5M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Saturna Capital's largest Q4 2019 buy was Sony: 87,500 shares worth $1.19M.
  • Saturna Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $13.2M increase.
  • Saturna Capital's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $23.5M.
  • Saturna Capital fully exited Celgene Corp in Q4 2019, selling an estimated $20.4M.
  • Saturna Capital's ten largest holdings make up 31% of its $3.7B portfolio in Q4 2019.
  • Saturna Capital opened 8 new positions and closed 6 in Q4 2019.
  • Saturna Capital's portfolio value rose 7.4% quarter-over-quarter to $3.7B.

Based on Saturna Capital's 13F filing for Q4 2019, filed 13 Feb 2020.